Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

• প্রধান লেখক: Giuseppe Remuzzi (লেখক), Ruth Campbell (লেখক), Piero Ruggenenti (লেখক), Varusca Brusegan (লেখক), Paolo Cravedi (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2010-01-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

We have studied the effects of add-on spironolactone treatment (100 mg/day) in 11 patients with idiopathic membranous nephropathy (IMN) and > 3 gm proteinuria/day despite angiotensin converting enzyme (ACE) inhibitor therapy titrated to a systolic/diastolic blood pressure < 120/80 mmHg. Blood...